Cancers is a leading peer-reviewed journal published by MDPI, dedicated to advancing the field of oncology and cancer research. Established in 2009 and based in Switzerland, this Open Access journal provides a platform for the rapid dissemination of high-quality research findings, reviews, and clinical studies related to all aspects of cancer biology and treatment. With an impressive impact factor and recognized as Q1 in Oncology and Q2 in Cancer Research for 2023, Cancers strives to foster a collaborative environment among researchers, healthcare professionals, and students seeking to deepen their knowledge and understanding of cancer. The journal’s commitment to accessibility and its broad scope make it an invaluable resource for anyone passionate about combating cancer and improving patient outcomes. For more information and to access its diverse publications, visit the journal’s website.

Palliative Medicine is a premier journal dedicated to advancing the field of palliative care, published by SAGE Publications Ltd. Established in 1987 and continuing through 2024, this esteemed journal focuses on the integration of pain management and comprehensive care for patients with life-limiting illnesses. With its impressive impact factor and a prestigious Q1 ranking in both Anesthesiology and Pain Medicine, as well as in Medicine (miscellaneous), it stands as a critical resource for researchers, healthcare professionals, and students engaged in this vital area of medicine. The journal emphasizes original research, reviews, and clinical studies that contribute to the understanding and practice of palliative care, promoting improved quality of life and support for patients and their families. Although not open access, articles are accessible through institutional subscriptions, ensuring the dissemination of knowledge to a wide audience. Whether you are a seasoned researcher or an emerging professional in the field, Palliative Medicine remains an invaluable platform for scholarly exchange and innovation.

JOURNAL OF PSYCHOSOCIAL ONCOLOGY, published by Routledge Journals, Taylor & Francis Ltd, serves as a pivotal platform in the interdisciplinary field of psychosocial oncology, providing critical insights into the psychological, social, and emotional aspects impacting cancer patients and their families. With a storied history dating back to 1983 and converging until 2024, this journal holds a prestigious positioning, ranked in the Q2 category for Applied Psychology and Q3 for both Oncology and Psychiatry & Mental Health in 2023, highlighting its integral role in these overlapping fields. Despite not currently offering an open access model, the journal continues to attract a broad spectrum of scholars with its impactful research, evidenced by its Scopus rankings within the 50th to 58th percentile across related categories. Researchers, clinicians, and students alike will find the journal’s focus on the psychosocial dimensions of cancer to be invaluable, as it advances knowledge and practice aimed at improving patient outcomes and well-being in the cancer care continuum.

INTENSIVE CARE MEDICINE is a premier academic journal in the field of critical care and intensive care medicine, published by SPRINGER. With an impressive HIndex and a remarkable impact factor, this journal consistently ranks in the top quartile of its category, achieving Q1 status for 2023. Spanning over four decades since its inception in 1977, it serves as a crucial platform for disseminating groundbreaking research and clinical advancements that shape the future of intensive care. Notably, it holds a distinguished position in the Scopus rankings, placed #1 out of 110 in its field, reflecting its importance and influence among researchers and clinicians alike. Although it is not an open-access journal, it offers various subscription options, ensuring wide accessibility to its high-quality content. The journal is dedicated to enhancing knowledge and practices within the critical care community, making it an indispensable resource for practitioners, researchers, and students pursuing excellence in intensive care medicine.

Lung Cancer Management, published by FUTURE MEDICINE LTD, is a premier academic journal dedicated to the evolving field of oncology and respiratory medicine. With an ISSN of 1758-1966 and an E-ISSN of 1758-1974, this journal offers a platform for the dissemination of cutting-edge research, clinical studies, and expert reviews, all focusing on the latest advances in lung cancer treatment and management. Despite being a relatively new entry since its inception in 2014 and achieving its converged years from 2020 to 2024, it has already established itself in the Q3 quartile for both oncology and pulmonary and respiratory medicine as of 2023, according to category quartiles rankings. With a Scopus ranking of #98 in the category of Pulmonary and Respiratory Medicine and #266 in Oncology, the journal reflects a commitment to quality and relevance in its content. Although it does not offer open access, it remains a crucial resource for researchers, clinicians, and students seeking to stay informed about the latest developments and practical approaches in lung cancer management. The journal is accessible from its base in the United Kingdom, at UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB, ensuring that it caters to a global audience eager to explore and contribute to this vital field of medicine.

Medecine Palliative is a distinguished journal published by Elsevier, dedicated to the vital field of palliative care and pain management. With an ISSN of 1636-6522 and E-ISSN 2213-0098, this international journal has been an essential resource since its inception in 1970, currently covering research from 2004 to 2024. The journal reflects a commitment to enhancing the quality of life for patients facing serious illnesses, addressing critical issues in Anesthesiology and Oncology, while fostering innovative nursing practices in palliative care. While the journal holds a Q3 ranking in Anesthesiology and Pain Medicine and a Q4 in Oncology categories, making it a valuable venue for researchers and practitioners aiming to contribute to the evolving landscape of palliative medicine. Despite its lower rank in some categories, the journal serves as an important platform for insights, clinical findings, and current practices that can significantly impact patient care. Medecine Palliative is accessible to researchers, professionals, and students who are eager to explore the latest advancements and evidence-based approaches in end-of-life care.

Seminars in Oncology Nursing, published by Elsevier Science Inc, serves as a cornerstone for the field of oncology nursing, facilitating the dissemination of high-quality research and clinical practice insights since 1985. This quarterly journal, with significant impact as reflected in its Q2 ranking in the Nursing category for Oncology, provides an essential platform for the authors to share their findings, experiences, and innovations that can enhance patient care in oncology settings. With its ISSN 0749-2081 and E-ISSN 1878-3449, the journal offers a comprehensive access to a wealth of articles that emphasize evidence-based practices, care models, and the evolving challenges faced by oncology nurses. Targeted towards researchers, clinicians, and students, Seminars in Oncology Nursing not only contributes to academic discourse but also supports the professional development of its readership, ultimately advancing the field of oncology nursing.

Asia-Pacific Journal of Oncology Nursing, published by Elsevier Science Inc, serves as a vital resource for researchers, practitioners, and students involved in the fields of oncology and nursing within the Asia-Pacific region. Since its transition to Open Access in 2014, the journal has aimed to disseminate cutting-edge research and innovative practices that enhance the quality of nursing care in oncology. With its ISSN 2347-5625 and E-ISSN 2349-6673, this journal holds a Q3 rank in both Oncology and Nursing (Oncology Nursing) as of 2023, reflecting its commitment to addressing current challenges and advancements in the discipline. With a Scopus ranking of 252/404 in Medicine (Oncology) and 13/20 in Nursing (Oncology Nursing), it occupies a crucial position in the academic landscape, nurturing knowledge that directly impacts patient care in oncology settings. Located at STE 800, 230 Park Ave, New York, NY 10169, the journal encourages contributions that explore multifaceted aspects of oncology nursing from 2018 to 2024, making it an important platform for emerging voices and established experts alike.

Current Oncology Reports is a prestigious academic journal dedicated to the field of oncology, published by Springer and based in the United States. With an impressive impact factor and ranking as a Q1 journal in the 2023 category of Oncology, it positions itself among the top-tier publications within the discipline. Established in 1999, the journal has been a vital resource for researchers, professionals, and students alike, providing comprehensive insights and the latest advancements in cancer research and treatment. Through its rigorous peer-review process, Current Oncology Reports disseminates high-quality original articles, reviews, and clinical studies that foster collaboration and innovation in the oncology community. Although it currently operates under a subscription model, the journal remains committed to accessibility, ensuring that critical findings reach a broad audience. As such, it serves as an essential platform for those dedicated to the fight against cancer, making significant contributions to the evolving landscape of oncology.

CURRENT PROBLEMS IN CANCER is an esteemed journal published by MOSBY-ELSEVIER, dedicated to advancing the field of oncology and cancer research. With an ISSN of 0147-0272 and an E-ISSN of 1535-6345, it has been a vital resource for over four decades, converging years of expertise from 1976 to 2024. The journal is recognized for its impactful contribution to the field, currently holding a Q3 ranking in Cancer Research and a Q2 ranking in Oncology, reflecting its importance in disseminating significant advancements and discussions in the field. It is ranked #164 out of 404 in Medicine _ Oncology and #131 out of 230 in Biochemistry, Genetics and Molecular Biology _ Cancer Research on Scopus, indicating its relevance and reach among academic circles. Although it does not offer open access, the journal remains a crucial platform for researchers and professionals seeking to explore contemporary issues in cancer treatment and management. With its commitment to quality and innovation, CURRENT PROBLEMS IN CANCER serves as an essential conduit for knowledge sharing and research development in oncology and cancer science.